Schedule 13G

430 Schedule 13G filing by BlackRock

BlackRock reported beneficial ownership of 3.4M shares, representing 5.5% of TERNS PHARMACEUTICALS INC in this filing.

FiledJan 31, 2024

Ownership dateDec 31, 2023

Reported shares3.4M

Reported ownership5.5%

Ownership details

Voting and dispositive power reported in the filing

These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.

Sole voting power 3.4M

Shared voting power 3.4M

Sole dispositive power 3.4M

Shared dispositive power 3.4M

Source

Original filing and accession

Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.

Reporting filer: BlackRock
CIK: CIK0001364742
Accession: 0001086364-24-006006
Form: Schedule 13G

Open SEC filing View 430 ownership history

Read the filing in context

Understand what a Schedule 13 filing does—and does not—tell you.

How to read a Schedule 13G → Does a 13G mean the shares were just bought? → Filing date vs. ownership date →